Merck Company Stock Today
| MRK Stock | USD 80.93 1.46 1.77% |
PerformanceWeak
| Odds Of DistressLow
|
Merck is selling for 80.93 as of the 8th of July 2025. This is a 1.77 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 80.7. Merck has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 8th of June 2025 and ending today, the 8th of July 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 13th of January 1978 | Category Healthcare | Classification Health Care |
Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. The company has 2.51 B outstanding shares of which 35.8 M shares are now shorted by investors with about 2.5 days to cover. More on Merck Company
Moving together with Merck Stock
Moving against Merck Stock
Merck Stock Highlights
ESG Sustainability
Environment Score | Governance Score | Social Score |
| Chairman | Kenneth Frazier | ||||
| Thematic Ideas | Showing 3 out of 4 themes | ||||
| Old Names | [Merck & Company Inc, Marka S.A., Merck & Company Inc, Merck & Company Inc] | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Dow Jones Industrial, DAX Index, NYSE Composite, SP 500 Index, DAX Price, ARCA Pharmaceutical, NYSE 100 Index, BETTERINVESTING 100 INDEX, Giant Impact, Compulsion, Robots And Drones, Macroaxis Picks, Health Care, Pharmaceuticals, Drug Manufacturers—General, Healthcare (View all Sectors) | ||||
| Excise Tax Activities | Animal TestingCatholic | ||||
| Average Analyst Recommendation | |||||
Debt LevelsMerck can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Merck's financial leverage. It provides some insight into what part of Merck's total assets is financed by creditors.
| |||||
Merck Company (MRK) is traded on New York Stock Exchange in USA. It is located in 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 and employs 73,000 people. Merck is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 203.22 B. Merck Company runs under Pharmaceuticals sector within Health Care industry. The entity has 2.51 B outstanding shares of which 35.8 M shares are now shorted by investors with about 2.5 days to cover.
Merck Company has about 12.69 B in cash with 21.47 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.44.
Check Merck Probability Of Bankruptcy
Ownership AllocationMerck Company maintains a total of 2.51 Billion outstanding shares. The majority of Merck outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Merck Company to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Merck Company. Please pay attention to any change in the institutional holdings of Merck as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Merck Ownership Details
Merck Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Jpmorgan Chase & Co | 2025-03-31 | 28.5 M | |
| Fisher Asset Management, Llc | 2025-03-31 | 24.4 M | |
| Bank Of New York Mellon Corp | 2025-03-31 | 23.1 M | |
| Franklin Resources Inc | 2025-03-31 | 21.9 M | |
| Ubs Group Ag | 2025-03-31 | 21.1 M | |
| Ubs Asset Mgmt Americas Inc | 2025-03-31 | 20.7 M | |
| Legal & General Group Plc | 2025-03-31 | 19.8 M | |
| Deutsche Bank Ag | 2025-03-31 | 19.2 M | |
| Amvescap Plc. | 2025-03-31 | 15.3 M | |
| Vanguard Group Inc | 2025-03-31 | 252.5 M | |
| Blackrock Inc | 2025-03-31 | 225.4 M |
Merck Historical Income Statement
Merck Stock Against Markets
Merck Corporate Directors
| Thomas Glocer | Lead Independent Director | Profile | |
| Christine Seidman | Independent Director | Profile | |
| Kathy Warden | Independent Director | Profile | |
| Paul Rothman | Independent Director | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.075 | Dividend Share 3.12 | Earnings Share 6.88 | Revenue Per Share 25.271 | Quarterly Revenue Growth (0.02) |
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.